Convergent-T-1470 ProTouch
One of the most hemostatic soft tissue laser on the market
The ProTouch is the first 1470nm laser system designed specifically for treating BPH. Its 1470 nm wavelength is highly absorbed by both water and hemoglobin making it ideal for ablating soft tissue. As the laser energy ablates tissue, it simultaneously seals off the blood vessels to minimize bleeding. In contrast to 532nm KTP lasers, the ProTouch’s patented fiber tip protection system allows the surgeon to operate in contact mode, which provides the tactile feel of a scalpel or electrode loop without destroying the fiber.
The T-1470 laser allows the surgeon to enucleate prostate tissue similar to the high powered holmium laser but with better coagulation than the holmium laser. The ablative properties of the T-1470 laser are superior to the holmium laser and comparable to the KTP laser. The T-1470 laser may also help surgeons transition from ablative technique to enucleation techniques. The T-1470 laser should prove to be an important tool in the laser management of BPH.
The T-1470 ProTouch Diode laser is a clinically unique new laser. After 30 years experience using multiple wavelengths in urologic laser surgery, I found the T-1470 ProTouch laser provides excellent vaporization and coagulation for resection of prostate tissue, bladder tumors, bladder neck contractures, urethral strictures, and excision of penile neoplasms. After completing over 32 cases I have been impressed with this laser’s efficacy and minimal side effects. This cost effective laser uses standard 110 volt current and weighs only 55 pounds. This unit is significantly smaller than its competitors while delivering remarkably complete laser tissue interaction.
It’s like a “Bovie” on a tip of a laser fiber, only it coagulates better with less unwanted collateral tissue damage. The huge advantage of this laser is that it allows urologists to perform surgery without bleeding-enabling a clear field and controlled operation.
The T-1470 laser allows the surgeon to enucleate prostate tissue similar to the high powered holmium laser but with better coagulation than the holmium laser. The ablative properties of the T-1470 laser are superior to the holmium laser and comparable to the KTP laser. The T-1470 laser may also help surgeons transition from ablative technique to enucleation techniques. The T-1470 laser should prove to be an important tool in the laser management of BPH.
This extremely versatile and hemostatic laser energy is optimally suited for BPH adenoma enucleation, however it can be just as valuable and performing partial nephrectomy and critical aspects of minilap open radical prostatectomy.
The shallow depth of penetration of the ProTouch prevents injury to the nerve endings and very reliably preserves sexual potency. It enucleates tissue circumferentially in a very comfortable fashion and allows thorough opening of the prostatic urethra. The end result has been as good as a suprapubic prostatectomy.
Patients have been very pleased with the Transurethral Laser Enucleation of the Prostate (TLEP). The ProTouch provides a unique combination of thorough enucleation, low risk and rapid recovery. Quality of life is markedly improved while protecting and preserving bladder and renal function.